UK Companies House feature
A.& F.A. DUNDEE LIMITED
Profile
- Company number
- NI003932
- Status
- Active
- Incorporation
- 1957-08-22
- Last accounts made up
- 2024-08-31
- Account category
- FULL
- Primary SIC
- 47730
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG, Chartered Accountants
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the company or to cease its operations, and as they have concluded that the company's financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”
Subsidiaries
- Medicare (NI) Limited · 100% held · Northern Ireland · Dormant
- Health Store Shares · 100% held · Northern Ireland · Dormant
- Omapharm Limited · 13% held · Northern Ireland · Retail pharmacy
Significant events
- “The directors expect the general level of activity to increase given the group restructuring on 31 August 2024.”
- “On 2 August 2024, the entire share capital of the company was indirectly acquired by Quadrapharm Limited as part of a wider group restructuring exercise.”
- “On 31 August 2024, the trade and net assets of these subsidiaries were then subsequently transferred to the company at book value and consequently the investments were written down to recoverable amount before being transferred back to Magir Limited.”
- “Magir Limited then transferred all its trade and net assets to the company at book value.”
- “The company also acquired a third party loan and lent the proceeds to Quadrapharm Limited. Quadrapharm Limited then subscribed for shares in Magir Limited and the latter used the funds to settle its outstanding debt with the same lender.”
- “The purpose of this exercise is to separate the property assets from the trading assets of Magir Limited.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GEDDIS, Michael David | Secretary | 2008-06-05 | — | British |
| GEDDIS, Michael David | Director | 2008-06-05 | Sep 1965 | British |
| GUERIN, Michael Francis | Director | 2008-06-05 | Jun 1963 | Irish |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DUNDEE, Heather | Secretary | 2008-03-14 | 2008-06-05 |
| DUNDEE, Wilhelmina | Secretary | 1957-08-22 | 2008-03-14 |
| DUNDEE, Frederick Alexander | Director | 1957-08-22 | 2006-11-25 |
| DUNDEE, Timothy Alexander | Director | 1957-08-22 | 2008-06-05 |
| MCKEGNEY, Aidan Gerard | Director | 2020-12-21 | 2022-03-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Quadrapharm Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2024-08-31 | Active |
| Mr Michael Francis Guerin | Individual | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-10-07 | Ceased 2024-08-31 |
| Udg Healthcare (Uk) Holdings Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-10-07 | Ceased 2018-07-02 |
Filing timeline
Last 20 of 186 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-23 | AA | accounts | accounts with accounts type full |
| 2024-10-07 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-09-12 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-09-12 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-09-11 | RESOLUTIONS | resolution | resolution |
| 2024-09-11 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-09-10 | SH01 | capital | capital allotment shares |
| 2024-06-04 | AA | accounts | accounts with accounts type full |
| 2023-10-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-05-31 | AA | accounts | accounts with accounts type full |
| 2022-10-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-05-27 | AA | accounts | accounts with accounts type full |
| 2022-04-05 | TM01 | officers | termination director company with name termination date |
| 2022-01-04 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2021-10-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-06-01 | AA | accounts | accounts with accounts type full |
| 2021-03-02 | AA | accounts | accounts with accounts type full |
| 2021-01-29 | AP01 | officers | appoint person director company with name date |
| 2020-10-14 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.